Catalent Pharma Solutions has opened a large scale expansion at its Winchester, KY, manufacturing facility, doubling its footprint to 180,000 sq. ft. The expansion features newly installed fluid bed capacity, expanded analytical labs, and an advanced, open facility design that provides flexibility to support the requirements of new customer programs for complex, oral solid formulations.
 
Catalent’s Winchester facility has experience in product development, technology transfer and commercial manufacturing, and has produced more than 3 billion tablets and capsules annually and launched more than 100 new products since its inception.
 
John Chiminski, Catalent’s president and chief executive officer said, “The Winchester facility has grown through its continued investment in technical expertise and capability, and through employing a flexible business model to support tailored manufacturing solutions for its customers. This flexibility, along with our proven track record of success with technology transfers and product launches, has clearly driven increased demand for manufacturing services at Winchester, and our latest capacity expansion allows us to manufacture substantial marketed products for both new and existing customers.”
 
The expansion began in 2013 with a $35 million investment, followed by a subsequent investment in additional fluid bed capacity. The expansion will add as many as 140 new employees at the site, with potential to add further employees and capabilities in the future.